✦ LIBER ✦

Outpatient high-dose melphalan in multiple myeloma patients

✍ Scribed by Mohamad Kassar; Erin Medoff; Stuart Seropian; Dennis L. Cooper

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Repeat administration of high dose melph

✍ Mansi, JL; Cunningham, D; Viner, C; Ellis, E; Meldrum, M; Milan, S; Gore, M 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 925 KB

Bortezomib, low-dose intravenous melphal

✍ Rakesh Popat; Heather Oakervee; Catherine Williams; Mark Cook; Charles Craddock; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

High dose melphalan or intermediate dose

✍ M. Bishton; M. Gilyead; E. Das Gupta; C. Williams; N.H. Russell; J.L. Byrne 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Fludarabine/melphalan conditioning for a

✍ Giralt, S; Aleman, A; Anagnostopoulos, A; Weber, D; Khouri, I; Anderlini, P; Mol 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 93 KB

The NK1 receptor antagonist aprepitant d

✍ Gerlinde Egerer; Kathrin Eisenlohr; Martina Gronkowski; Juergen Burhenne; Klaus- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

MBL2 polymorphism and risk of severe inf

✍ Mølle, I; Peterslund, N A; Thiel, S; Steffensen, R 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 125 KB